Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.20
-2.19 (-26.10%)
At close: Nov 13, 2026, 4:00 PM EST
6.10
-0.10 (-1.61%)
After-hours: Nov 13, 2026, 7:55 PM EST
Candel Therapeutics Employees
Candel Therapeutics had 55 employees as of December 31, 2025. The number of employees increased by 17 or 44.74% compared to the previous year. That makes Candel Therapeutics the 34,637th largest employer in the world and 4,591st in the United States.
Employees
55
Change (1Y)
17
Growth (1Y)
44.74%
Revenue / Employee
n/a
Profits / Employee
-$1,802,455
Market Cap
486.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 55 | 17 | 44.74% |
| Dec 31, 2024 | 38 | -4 | -9.52% |
| Dec 31, 2023 | 42 | -34 | -44.74% |
| Dec 31, 2022 | 76 | 11 | 16.92% |
| Dec 31, 2021 | 65 | 24 | 58.54% |
| Mar 31, 2021 | 50 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| Wave Life Sciences | 317 |
| Geron | 258 |
| Olema Pharmaceuticals | 150 |
| Cullinan Therapeutics | 109 |
| Helus Pharma | 100 |
| Aclaris Therapeutics | 73 |
| Zevra Therapeutics | 61 |
CADL News
- 2 days ago - Candel Therapeutics price target lowered to $11 from $15 at Freedom Broker - TheFly
- 2 days ago - Candel Therapeutics price target lowered to $18 from $23 at H.C. Wainwright - TheFly
- 2 days ago - Candel Therapeutics price target lowered to $13 from $25 at Canaccord - TheFly
- 2 days ago - Candel Therapeutics price target lowered to $15 from $18 at BofA - TheFly
- 2 days ago - Candel Therapeutics price target lowered to $19 from $22 at Stifel - TheFly
- 3 days ago - Candel Therapeutics says in ongoing dialogue with FDA on aglatimagene BLA - TheFly
- 3 days ago - Candel Therapeutics reports Q3 EPS (28c), consensus (31c) - TheFly
- 3 days ago - Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire